MIRABEGRON

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 68180-151
  • Package NDC 68180-151-06
  • Package NDC 68180-151-09
  • Application number ANDA209485
  • SPL ID b26f08e4-dfe4-4a0f-b6b5-e9abb495e415
  • SPL set ID d22d3d12-8466-46db-bc19-d13e87c6115c
  • UNII MVR3JL3B2V
  • RxCUI 1300791
  • RxCUI 1300801

What the source publishes

Labeler
Lupin Pharmaceuticals, Inc.
Active ingredients
mirabegron
Form
TABLET, FILM COATED, EXTENDED RELEASE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:68180-151_b26f08e4-dfe4-4a0f-b6b5-e9abb495e415
{
  "name": "MIRABEGRON",
  "splId": "b26f08e4-dfe4-4a0f-b6b5-e9abb495e415",
  "labels": [
    {
      "setId": "d22d3d12-8466-46db-bc19-d13e87c6115c",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d22d3d12-8466-46db-bc19-d13e87c6115c",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d22d3d12-8466-46db-bc19-d13e87c6115c"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Lupin Pharmaceuticals, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68180-151-06)",
      "package_ndc": "68180-151-06",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20240419"
    },
    {
      "sample": false,
      "description": "90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68180-151-09)",
      "package_ndc": "68180-151-09",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20240419"
    }
  ],
  "productId": "68180-151_b26f08e4-dfe4-4a0f-b6b5-e9abb495e415",
  "useDomain": "unknown",
  "dosageForm": "TABLET, FILM COATED, EXTENDED RELEASE",
  "productNdc": "68180-151",
  "deaSchedule": null,
  "genericName": "mirabegron",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "MIRABEGRON",
      "strength": "25 mg/1"
    }
  ],
  "applicationNumber": "ANDA209485",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20240419",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000185008",
      "N0000185007",
      "N0000182137",
      "N0000190114",
      "N0000185503"
    ],
    "upc": [
      "0368180152064",
      "0368180151067"
    ],
    "unii": [
      "MVR3JL3B2V"
    ],
    "rxcui": [
      "1300791",
      "1300801"
    ],
    "spl_set_id": [
      "d22d3d12-8466-46db-bc19-d13e87c6115c"
    ],
    "pharm_class_epc": [
      "beta3-Adrenergic Agonist [EPC]"
    ],
    "pharm_class_moa": [
      "Adrenergic beta3-Agonists [MoA]",
      "Cytochrome P450 2D6 Inhibitors [MoA]",
      "Cytochrome P450 3A Inhibitors [MoA]",
      "P-Glycoprotein Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "Lupin Pharmaceuticals, Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:68180-151_b26f08e4-dfe4-4a0f-b6b5-e9abb495e415"